Levetiracetam-d6

• CAT Number: R047353
• CAS Number: 1133229-30-7
• Molecular Formula: C8H14N2O2
• Molecular Weight: 176.25
• Purity: ≥95%
• Synonyms: (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide-d6; (-)-Levetiracetam-d6; Keppra-d6; Levesam 500-d6; UCB-L 059-d6
• Storage: Store at -20°C
• IUPAC Name: (2S)-2-(2,2,3,3,4,4-hexadeuterio-5-oxopyrrolidin-1-yl)butanamide
• InChI: InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1/i3D2,4D2,5D2
• InChIKey: HPHUVLMMVZITSG-QXMLZOKMSA-N
• SMILES: [2H]C1(C(=O)N(C(C1([2H])[2H])([2H])[2H])[C@@H](CC)C(=O)N)[2H]

Levetiracetam-d6（Cat No.:R047353） is a deuterated form of levetiracetam, a widely used antiepileptic drug, featuring six deuterium atoms. This isotopic enrichment enhances its stability and makes it invaluable in pharmacokinetic and metabolic studies, providing more accurate and sensitive analysis through mass spectrometry and NMR spectroscopy. It is crucial for exploring the drug’s metabolism and distribution within the body, facilitating the development of more effective dosing regimens and formulations. Levetiracetam-d6 aids researchers in better understanding how modifications to the molecular structure can impact therapeutic efficacy and safety in epilepsy treatment.